Almost a decade ago, LCI entered into the manufacturing sphere in both the Pharmaceuticals and Nutraceuticals segment, through the acquisition and setup of advanced manufacturing facilities.
These developments are a testament to our commitment to growth and to providing high-quality healthcare solutions to our customers. The manufacturing of our Pharmaceuticals and Nutraceuticals is carried out through three pharmaceuticals and one nutraceutical facility.
The Company acquired Cirin Pharmaceuticals (Private) Limited in 2016 and along with it acquired its manufacturing facility in Hattar and its products. They include sterile liquid injectables and oral solid dosages for the segment of anti-infectives, anti-viral, analgesics, gastroenterology, intensive care, and anxiolytics.